Stem cell transplant for lymphoma - never too late?

por Cashen, Amanda F., Bartlett, Nancy L.
Publicado 2022

Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma

por Chen, Robert, Allibone, Suzanne, Bartlett, Nancy L, Brice, Pauline, Chen, Andy, Pose, Katrina, Rich, Lynn, Bonthapally, Vijay, Garfin, Phillip M, Fanale, Michelle
Publicado 2016

A phase 1 first‐in‐human study of GS‐0189, an anti‐signal regulatory protein alpha (SIRPα) monoclonal antibody, in patients with relapsed/refractory (R/R) non‐Hodgkin lymphoma (NHL...

por Narkhede, Mayur, Bartlett, Nancy L., Ibrahimi, Sami, Popplewell, Leslie, Seto, Anna, Bates, Jamie, Lee, Yeonju, Ganti, Vaishnavi, Han, Ling, Chen, Tianling, Patel, Manish R.
Publicado 2023

Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma

por Jagadeesh, Deepa, Horwitz, Steve, Bartlett, Nancy L, Kim, Youn, Jacobsen, Eric, Duvic, Madeleine, Little, Meredith, Trepicchio, William, Fenton, Keenan, Onsum, Matthew, Lisano, Julie, Advani, Ranjana
Publicado 2022

The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials

por Lansigan, Frederick, Barak, Ian, Pitcher, Brandelyn, Jung, Sin‐Ho, Cheson, Bruce D., Czuczman, Myron, Martin, Peter, Hsi, Eric, Schöder, Heiko, Smith, Scott, Bartlett, Nancy L., Leonard, John P., Blum, Kristie A.
Publicado 2018

Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL

por Martin, Peter, Bartlett, Nancy L., Chavez, Julio C., Reagan, John L., Smith, Sonali M., LaCasce, Ann S., Jones, Jeffrey, Drew, James, Wu, Chengqing, Mulvey, Erin, Revuelta, Maria V., Cerchietti, Leandro, Leonard, John P.
Publicado 2022

Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies

por Bartlett, Nancy L, Chen, Robert, Fanale, Michelle A, Brice, Pauline, Gopal, Ajay, Smith, Scott E, Advani, Ranjana, Matous, Jeffrey V, Ramchandren, Radhakrishnan, Rosenblatt, Joseph D, Huebner, Dirk, Levine, Pamela, Grove, Laurie, Forero-Torres, Andres
Publicado 2014

A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors

por de Vos, Sven, Forero-Torres, Andres, Ansell, Stephen M, Kahl, Brad, Cheson, Bruce D, Bartlett, Nancy L, Furman, Richard R, Winter, Jane N, Kaplan, Henry, Timmerman, John, Whiting, Nancy C, Drachman, Jonathan G, Advani, Ranjana
Publicado 2014

Is local review of positron emission tomography scans sufficient in diffuse large B‐cell lymphoma clinical trials? A CALGB 50303 analysis

por Torka, Pallawi, Pederson, Levi D., Knopp, Michael V., Poon, David, Zhang, Jun, Kahl, Brad S., Higley, Howard R., Kelloff, Gary, Friedberg, Jonathan W., Schwartz, Lawrence H., Wilson, Wyndham H., Leonard, John P., Bartlett, Nancy L., Schöder, Heiko, Ruppert, Amy S.
Publicado 2023

Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R

por Lakhotia, Rahul, Dunleavy, Kieron, Abramson, Jeremy S., Link, Brian K., Powell, Bayard L., Melani, Christopher, Lucas, Andrea N., Steinberg, Seth M., Friedberg, Jonathan W., Kahl, Brad S., Little, Richard F., Bartlett, Nancy L., Noy, Ariela, Wilson, Wyndham H., Roschewski, Mark
Publicado 2023

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

por Locke, Frederick L., Neelapu, Sattva S., Bartlett, Nancy L., Siddiqi, Tanya, Chavez, Julio C., Hosing, Chitra M., Ghobadi, Armin, Budde, Lihua E., Bot, Adrian, Rossi, John M., Jiang, Yizhou, Xue, Allen X., Elias, Meg, Aycock, Jeff, Wiezorek, Jeff, Go, William Y.
Publicado 2017

P1129: GLOFITAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL): EXTENDED FOLLOW-UP AND LANDMARK ANALYSES FROM A PIVOTAL PHASE II STUDY

por Hutchings, Martin, Carlo-Stella, Carmelo, Morschhauser, Franck, Dickinson, Michael, Bachy, Emmanuel, Cartron, Guillaume, Khan, Cyrus, Tani, Monica, Martinez-Lopez, Joaquín, Bartlett, Nancy L., Salar, Antonio, Brody, Joshua, Leppa, Sirpa, Baumlin, Pauline, Lundberg, Linda, Relf, James, Xie, Yuying, Bottos, Alessia, Humphrey, Kathryn, Falchi, Lorenzo
Publicado 2023

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study

por Annunzio, Kaitlin, Grover, Natalie S., Welkie, Rina Li, Torka, Pallawi, Watkins, Marcus P., Anampa-Guzmán, Andrea, Tavakkoli, Montreh, Oh, Timothy S., Reves, Heather, Jones, Daniel, Hanel, Walter, Christian, Beth, Ramakrishnan Geethakumari, Praveen, Karmali, Reem, Barta, Stefan K., Bartlett, Nancy L., Olszewski, Adam J., Epperla, Narendranath
Publicado 2023

Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma

por Jaswal, Shama, Sanders, Vanessa, Pullarkat, Priyanka, Teja, Stephanie, Salter, Amber, Watkins, Marcus P., Atagu, Norman, Ludwig, Daniel R., Mhlanga, Joyce, Mellnick, Vincent M., Peterson, Linda R., Bartlett, Nancy L., Kahl, Brad S., Fehniger, Todd A., Ghobadi, Armin, Cashen, Amanda F., Mehta-Shah, Neha, Ippolito, Joseph E.
Publicado 2022

Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2

por Barr, Paul M., Robak, Tadeusz, Owen, Carolyn, Tedeschi, Alessandra, Bairey, Osnat, Bartlett, Nancy L., Burger, Jan A., Hillmen, Peter, Coutre, Steven, Devereux, Stephen, Grosicki, Sebastian, McCarthy, Helen, Li, Jianyong, Simpson, David, Offner, Fritz, Moreno, Carol, Zhou, Cathy, Styles, Lori, James, Danelle, Kipps, Thomas J., Ghia, Paolo
Publicado 2018

Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study

por Epperla, Narendranath, Zhao, Qiuhong, Karmali, Reem, Torka, Pallawi, Shea, Lauren, Oh, Timothy S., Anampa-Guzmán, Andrea, Reves, Heather, Tavakkoli, Montreh, Greenwell, Irl Brian, Hansinger, Emily, Umyarova, Elvira, Annunzio, Kaitlin, Sawalha, Yazeed, Christian, Beth, Thomas, Colin, Barta, Stefan K., Geethakumari, Praveen Ramakrishnan, Bartlett, Nancy L., Grover, Natalie S., Olszewski, Adam J.
Publicado 2023

Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma

por Neelapu, Sattva S., Locke, Frederick L., Bartlett, Nancy L., Lekakis, Lazaros J., Reagan, Patrick M., Miklos, David B., Jacobson, Caron A., Braunschweig, Ira, Oluwole, Olalekan O., Siddiqi, Tanya, Lin, Yi, Crump, Michael, Kuruvilla, John, Van Den Neste, Eric, Farooq, Umar, Navale, Lynn, DePuy, Venita, Kim, Jenny J., Gisselbrecht, Christian
Publicado 2021

P009: Improved Overall Survival with First-Line Brentuximab Vedotin plus Chemotherapy in Patients with Advanced Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHE...

por Hutchings, Martin, Ansell, Stephen M., Connors, Joseph M., Kim, Won Seog, Gallamini, Andrea, Ramchandren, Radhakrishnan, Friedberg, Jonathan W., Advani, Ranjana, Evens, Andrew M., Smolewski, Piotr, Savage, Kerry J., Bartlett, Nancy L., Eom, Hyeon-Seok, Abramson, Jeremy S., Dong, Cassie, Campana, Frank, Fenton, Keenan, Puhlmann, Markus, Straus, David J., Radford, John
Publicado 2022

P1078: MOSUNETUZUMAB DEMONSTRATES DURABLE RESPONSES IN PATIENTS WITH RELAPSED AND/OR REFRACTORY FOLLICULAR LYMPHOMA WHO HAVE RECEIVED ≥2 PRIOR THERAPIES: UPDATED ANALYSIS OF A PIVO...

por Sehn, Laurie H., Bartlett, Nancy L., Matasar, Matthew, Schuster, Stephen J., Assouline, Sarit, Kuruvilla, John, Shadman, Mazyar, Cheah, Chan, Fay, Keith, Ku, Matthew, Nastoupil, Loretta J., Wei, Michael, Yin, Shen, To, Iris, Hu, Nan, Min, Juliana, Penuel, Elicia, Belousov, Anton, Coimbra, Alexandre, Jemaa, Skander, Bender, Brendan, Turner, David, Elizabeth Budde, L.
Publicado 2023

Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202

por Ruppert, Amy S., Booth, Allison M., Ding, Wei, Bartlett, Nancy L., Brander, Danielle M., Coutre, Steven, Brown, Jennifer R., Nattam, Sreenivasa, Larson, Richard A., Erba, Harry, Litzow, Mark, Owen, Carolyn, Kuzma, Charles S., Abramson, Jeremy S., Little, Richard F., Smith, Scott E., Stone, Richard M., Byrd, John C., Mandrekar, Sumithra J., Woyach, Jennifer A.
Publicado 2021